US OptionsDetailed Quotes
DNA241220C7000
- 3.10
- +1.40+82.35%
15min DelayClose Dec 20 16:00 ET
3.60High3.10Low
3.60Open1.70Pre Close44 Volume266 Open Interest7.00Strike Price14.04KTurnover9744.40%IV0.20%PremiumDec 20, 2024Expiry Date3.08Intrinsic Value100Multiplier-2DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.9667Delta0.0351Gamma3.25Leverage Ratio-43.8307Theta0.0000Rho3.14Eff Leverage0.0000Vega
Ginkgo Bioworks Stock Discussion
Sign in to post a comment
$Ginkgo Bioworks (DNA.US)$ Has taken a huge dump think time to add. That valuation is at historical lows.
7
1
$Ginkgo Bioworks (DNA.US)$ Comparing to biotech sector ETF we can see the drop on Thursday and Friday had nothing to do with the stock itself. This actually overcame the correlation to the biotech sector at open on Thursday following earnings but once buying stopped the sector pull took it down. That explains why MM was lowering the bid without any sells causing it. Guess paranoia RFK is going to shut down biotech companies or something. Nonsense.
1
$Ginkgo Bioworks (DNA.US)$ They wanted to see more improvement than this? Net loss and margin dramatically reduced. Some of revenue was deferred but still.. 616m cash on hand. Wtf is this nonsense
1
2
$Ginkgo Bioworks (DNA.US)$ why is this down on good news?
2
$Ginkgo Bioworks (DNA.US)$A bounce from 7.70s signals an ascending triangle with a move back up to 10 resistance. Move to lower trend line was in low volume which is good.
2
1
$Ginkgo Bioworks (DNA.US)$ A bounce from 7.80s signals an ascending triangle with a move back up to 10 resistance. Move to lower trend line was in low volume which is good.
2
$Ginkgo Bioworks (DNA.US)$ Pullback to middle b-band on 4H after hitting resistance but overall trend looks pretty bullish. Volume picking up. I can see a retest and likely a breakout. Expect it to move fast above that volume shelf. NFA
6
1
No comment yet
QMengColdJoke : still a fraud after 40 to 1 reverse split.
TechTrek Invest OP QMengColdJoke : That's a very emotional response. Where is the evidence? Have you notified the SEC of your findings?
What's the fraud?
Share price falling isn't fraudulent.
COVID profits fell considerably - again losing revenue streams.is not fraudulent.
Core buisiness is growing.
Good AI development.
Reducing cost.
Ginkgo has good long term.potential.